Clinical Trials Browser

Phase 1/2 × Hematologic Neoplasms × Inotuzumab Ozogamicin × Clear all

NCT01664910 2024-07-23

CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies

Phase 1/2 Completed

27 enrolled 12 charts

Other hematologic neoplasm

Hematologic Neoplasms